Email

 

Alexis Borisy is a successful biotechnology entrepreneur with over 15 years of experience building and operating innovative science based organizations. Alexis joined Third Rock Ventures in 2009 as an Entrepreneur-in-Residence and focuses on the formation, development and strategy of new companies.

 

Prior to joining Third Rock Ventures, Alexis founded CombinatoRx in 2000, serving as its CEO, and bringing the company public on the NASDAQ in an IPO. He has raised $750 million in financing and business development deals, and has authored numerous scientific papers and patents. Trained in chemistry and chemical biology at Harvard where he was a Howard Hughes Predoctoral Fellow, Borisy was honored as the MIT Technology Review Innovator of the Year. He was also chosen as the New England Entrepreneur of the Year in Life Sciences and was honored as a Presidential Scholar. Borisy’s undergraduate degree in chemistry is from the University of Chicago, and he did his graduate work in the laboratory of Dr. Stuart Schreiber at Harvard University. Borisy serves on the Board of the Biotechnology Industry Organization, is an Overseer at the Boston Museum of Science, and is the Chairman of Forma Therapeutics. As Entrepreneur-in-Residence at Third Rock Ventures, Borisy is currently the founding CEO of a new venture.

Administrative Support

• Julie Nguyen
  Administrative Assistant
  Email
  (617) 585-2006